7/5
Bioengineering
Bioengineering technology keeps track of living cells and tissues
A new chemistry technique developed by Jina Ko, assistant bioengineering professor, and colleagues allows for a wider range of fluorescent markers to be added to individual cells without damaging them in the process.
A new method could enable a patient’s own antibodies to eliminate their tumors
A team of researchers at Penn Engineering has developed a new methodology to help differentiate tumors from healthy, normal tissues.
Making chemical separation more eco-friendly with nanotechnology
Chemical separation processes are essential to manufacturing, but also consume high levels of energy. Penn Engineers are developing new membranes for energy-efficient membrane-based separations on a nanoscale level.
Five Penn students are 2022 Goldwater Scholars
Five juniors have received 2022 Goldwater Scholarships to pursue research careers in mathematics, the natural sciences, or engineering. Penn's newest Goldwater Scholars are Joshua Chen, Allison Chou, Shriya Karam, Laila Barakat Norford, and Andrew Sontag.
Newly discovered ‘encrypted peptides’ with antibiotic properties
A new study reports three distinct proteins in human plasma that have naturally occurring antibiotic properties.
Protein controlled by both light and temperature can inform cell signal pathways
Penn Engineering researchers have described a new type of optogenetic protein that can be controlled not only by light, but also by temperature, allowing for a higher degree of control in the manipulation of cellular pathways.
Refining data into knowledge, turning knowledge into action
Penn Engineering researchers are using data science to answer fundamental questions that challenge the globe—from genetics to materials design.
Three Penn faculty named Hastings Center Fellows
Holly Fernandez Lynch, Quayshawn Spencer, and Connie Ulrich have been named Hastings Center Fellows for deepening public understanding of complex ethical issues in health, health care, science, and technology.
Two Penn seniors named 2022 Rhodes Scholars
Two Penn seniors have been awarded Rhodes Scholarships for graduate study at the University of Oxford, Raveen Kariyawasam, from Colombo, Sri Lanka, and Nicholas Thomas-Lewis, from Kimball, Nebraska.
‘Encrypted’ peptides could be wellspring of natural antibiotics
An interdisciplinary team of Penn researchers have used a carefully designed algorithm to discover a new suite of antimicrobial peptides, or naturally occurring antibiotics, in the human genome.
In the News
Penn is establishing a $100M center to focus on the intersection of engineering and biomedicine
A planned Center for Precision Engineering for Health, housed in the School of Engineering and Applied Science, will focus on developing biomaterials for personalized medical treatments. “Engineering solutions to problems within human health is one of the grand challenges of the discipline,” Dean Vijay Kumar said. “Our faculty are already leading the charge against these challenges, and the Center will take them to new heights.”
FULL STORY →
Science vs science: The contradictory fight over whether electromagnetic hypersensitivity is real
Electromagnetic fields are everywhere, and especially so in recent years. To most of us, those fields are undetectable. But a small number of people believe they have an actual allergy to electromagnetic fields. Ken Foster, a professor emeritus of bioengineering, has heard these arguments before. “Activists would point to all these biological effects studies and say, ‘There must be some hazard’; health agencies would have meticulous reviews of literature and not see much of a problem.”
FULL STORY →
This L.A. start-up is building tiny injectable robots to attack tumors
Marc Miskin of the School of Engineering and Applied Science commented on a new startup that is developing remote-control medical microrobots. “I would give them a lot of credit for figuring out a space where they can make an impact and justify how they’ll be competitive with traditional pharmaceutical approaches,” he said.
FULL STORY →